News

With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease treatments, we are talking about treating meibomian gland dysfunction and evaporative dry eye.For decades, meibomian gland dysfunction treatment began and ended with warm compresses and baby shampoo scrubs. Medical advice consisted of insisting that your patient … [Read more...] about In-office dry eye treatments: Tried, true and new

Finding ways that AI best fits into clinical practice while learning how accurate and useful it can be, especially for patients, could help clinicians trust it more in their daily workflow.“I do think that AI in health care has a long way to go to be trusted by most of us,” James Barry, MD, MBA, neonatologist and professor of pediatrics-neonatology and medical director at … [Read more...] about Clinician involvement key to safe, trusted AI use in health care

To characterize the natural history of Bietti crystalline dystrophy (BCD), and to identify reliable outcome measures for detecting disease progression. … [Read more...] about Fundus Autofluorescence as a Sensitive Biomarker of Disease Progression in Bietti Crystalline Dystrophy

To investigate retinomic changes preceding glaucoma onset and explore their predictive value. … [Read more...] about Retinomics as a tool for glaucoma prediction

Topical treatment for advanced dry eye disease, levodopa and lower nAMD risk, slow cyclophotocoagulation vs micropulse laser surgery for IOP control, flavoprotein fluorescence imaging for optic disc drusen, strabismus surgery in adults with comitant exotropia. … [Read more...] about Weekly Journal Update — March 18, 2026